Literature DB >> 27269911

Cultural interpretations of the efficacy and side effects of antimalarials in Tanzania.

Vinay R Kamat1.   

Abstract

This paper examines the cultural interpretations and the perceived efficacy and side effects of antimalarials in Tanzania. Interviews with 56 mothers of children diagnosed with malaria revealed that they were nostalgic about chloroquine, a banned antimalarial. Additional findings indicated that a majority of the mothers had an overall negative disposition toward sulfadoxine-pyrimethamine (SP), the first-line antimalarial. Mothers considered the persistence of fever as the primary undesirable side effect of SP, while also mentioning a range of other side effects. Mothers who could not afford an alternative to SP, rationalized the drug's side effects as indicative of disease egress. It is argued that ethnographic studies of cultural perceptions of malaria and antimalarials provide useful perspectives on how people negotiate the identity of a febrile illness, and how they understand and interpret the efficacy of existing antimalarials. In acknowledging the intra-cultural variability in perceptions of malaria and antimalarials, health policy makers must be cautious when implementing a 'one drug fits all' approach to malaria control.

Entities:  

Keywords:  Tanzania; antimalarials; efficacy; ethnography; malaria; side effects

Year:  2009        PMID: 27269911     DOI: 10.1080/13648470903246854

Source DB:  PubMed          Journal:  Anthropol Med        ISSN: 1364-8470


  5 in total

1.  Patient-Reported Adverse Effects Associated with Combination Antiretroviral Therapy and Coadministered Enzyme-Inducing Antiepileptic Drugs.

Authors:  Melissa A Elafros; Gretchen L Birbeck; Joseph C Gardiner; Omar K Siddiqi; Izukanji Sikazwe; Nigel Paneth; Christopher M Bositis; Jason F Okulicz
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Designing adverse event forms for real-world reporting: participatory research in Uganda.

Authors:  Emma C Davies; Clare I R Chandler; Simeon H S Innocent; Charles Kalumuna; Dianne J Terlouw; David G Lalloo; Sarah G Staedke; Ane Haaland
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

3.  Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.

Authors:  Kamala Thriemer; Albino Bobogare; Benedikt Ley; Clarice Samo Gudo; Mohammad Shafiul Alam; Nick M Anstey; Elizabeth Ashley; J Kevin Baird; Charlotte Gryseels; Elodie Jambert; Marcus Lacerda; Ferdinand Laihad; Jutta Marfurt; Ayodhia Pitaloka Pasaribu; Jeanne Rini Poespoprodjo; Inge Sutanto; Walter R Taylor; Christel van den Boogaard; Katherine E Battle; Lek Dysoley; Prakash Ghimire; Bill Hawley; Jimee Hwang; Wasif Ali Khan; Rose Nani Binti Mudin; Maria Endang Sumiwi; Rukhsana Ahmed; M M Aktaruzzaman; Kiran Raj Awasthi; Azucena Bardaji; David Bell; Leonard Boaz; Faustina Helen Burdam; Daniel Chandramohan; Qin Cheng; Keobouphaphone Chindawongsa; Janice Culpepper; Santasabuj Das; Raffy Deray; Meghna Desai; Gonzalo Domingo; Wang Duoquan; Stephan Duparc; Rustini Floranita; Emily Gerth-Guyette; Rosalind E Howes; Cecilia Hugo; George Jagoe; Elvieda Sariwati; Sanya Tahmina Jhora; Wu Jinwei; Harin Karunajeewa; Enny Kenangalem; Bibek Kumar Lal; Chandra Landuwulang; Emmanuel Le Perru; Sang-Eun Lee; Leo Sora Makita; James McCarthy; Asrat Mekuria; Neelima Mishra; Esau Naket; Simone Nambanya; Johnny Nausien; Thang Ngo Duc; Thuan Nguyen Thi; Rinitis Noviyanti; Daniel Pfeffer; Gao Qi; Annisa Rahmalia; Stephen Rogerson; Iriani Samad; Jetsumon Sattabongkot; Ari Satyagraha; Dennis Shanks; Surender Nath Sharma; Carol Hopkins Sibley; Ali Sungkar; Din Syafruddin; Arunansu Talukdar; Joel Tarning; Feiko Ter Kuile; Suman Thapa; Minerva Theodora; Tho Tran Huy; Edward Waramin; Govert Waramori; Adugna Woyessa; Chansuda Wongsrichanalai; Nguyen Xuan Xa; Joon Sup Yeom; Lukas Hermawan; Angela Devine; Spike Nowak; Indra Jaya; Supargiyono Supargiyono; Koen Peeters Grietens; Ric N Price
Journal:  Malar J       Date:  2018-06-20       Impact factor: 2.979

4.  Residual Malaria: Limitations of Current Vector Control Strategies to Eliminate Transmission in Residual Foci.

Authors:  Mario H Rodriguez
Journal:  J Infect Dis       Date:  2021-04-27       Impact factor: 5.226

5.  "Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania.

Authors:  Peter E Mangesho; Joanna Reynolds; Martha Lemnge; Lasse S Vestergaard; Clare I R Chandler
Journal:  Malar J       Date:  2014-12-13       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.